|本期目录/Table of Contents|

[1]曹文庆,宁殿宾,冯 丽,等.氨肽酶N在乳腺癌血管生成中的作用及其与VEGF的相关性[J].天津医科大学学报,2015,21(01):39-42.
　CAO Wen-qing,NING Dian-bin,FENG Li,et al.Functions of aminopeptidase N in breast cancer angiogenesis and its correlation with VEGF[J].Journal of Tianjin Medical University,2015,21(01):39-42.
点击复制

氨肽酶N在乳腺癌血管生成中的作用及其与VEGF的相关性(PDF)
分享到：

《天津医科大学学报》[ISSN:1006-8147/CN:12-1259/R]

卷:
21卷
期数:
2015年01期
页码:
39-42
栏目:
临床医学
出版日期:
2015-01-20

文章信息/Info

Title:

Functions of aminopeptidase N in breast cancer angiogenesis and its correlation with VEGF

文章编号:
1006-8147（2015）0-0039-04
作者:
曹文庆;  宁殿宾;  冯 丽 ; 赵玉哲;  张 静
(河北省人民医院普外一科, 石家庄 050051)
Author(s):

CAO Wen-qing;  NING Dian-bin;  FENG Li;  ZHAO Yu-zhe;  ZHANG Jing

(Department of The First General Surgery, Hebei General Hospital, Shijiazhuang 050051，China）

关键词:
氨肽酶N/CD13; 免疫组织化学; 乳腺肿瘤; 血管内皮生长因子
Keywords:
aminopeptidase N/CD13;  immunohistochemistry;  breast cancer;  vascular endothelial growth factor
分类号:
R737.9
DOI:
-
文献标志码:
A
摘要:
目的：研究氨肽酶N（APN）在乳腺癌的表达及临床意义，并比较其与血管内皮生长因子（VEGF）的关系，探讨APN在乳腺癌血管生成中的作用。方法：采用免疫组织化学SP法检测APN在60例乳腺癌组织、20例癌旁正常乳腺组织中的表达。结果：APN主要表达于肿瘤细胞的细胞膜，APN在乳腺癌上的表达率【36.7%（22/60）】明显高于癌旁正常乳腺组织【0%（0/20）】（χ2=10.115，P=0.001）；APN在乳腺癌上的表达与病理类型有关（P=0.035）。乳腺癌组织内还可见新生血管内皮着色，而癌旁正常组织血管内皮无着色；相关性分析显示，乳腺癌组织APN与VEGF的表达无直线相关关系（rs =0.078，P =0.553），但VEGF阳性组APN表达率【44.7%（21/47）】高于VEGF阴性组【7.7%（1/13）】（χ2=4.512，P =0.034）。结论：APN与VEGF在乳腺癌血管发生中可能存在一定的协同作用，乳腺癌中APN的表达可提示预后不良，APN可以作为抗肿瘤血管药物中有力的靶点。
Abstract:

Objective: To investigate the expression and significance of aminopeptidase N (APN) in breast cancer, meanwhile, to explore the relationship between APN and vascular endothelial growth factor (VEGF), and to discuss the functions of APN in angiogenesis of breast cancer. Methods: Immunohistochemistry (SP means) was performed to measure the expression of APN in 60 cases of breast cancer tissues and 20 cases of adjacent normal breast tissues. Results: APN mainly was expressed in the membrane of malignant cells, and the positive rate of APN expression in breast cancer tissues was higher than that in adjacent normal breast tissues, 36.7% (22 out of 60) and 0% (0 out of 20) respectively (χ2=10.115, P=0.001). APN expression was associated with tumor pathological type (P=0.035). Furthermore , APN expression in neovascular endothelium was also observed in breast cancer tissues while no expression was found in normal endothelium. Under the correlation analysis, no linear correlation was found between the APN expression and VEGF expression (rs =0.078, P =0.553). However, The APN positive rates in VEGF positive group and in VEGF negative group were 44.7%（21 out of 47），7.7%（1 out of 13）respectively, showing the APN expression was more often observed in VEGF positive group than in VEGF negative group (χ2=4.512, P=0.034). Conclusion: A synergistic effect may exist between APN and VEGF in the function of tumor angiogenesis in breast cancer, and the expression of APN in breast cancer may indicates a poor prognosis. APN could function as an effective target in anti-cancer therapy.

参考文献/References:

[1]Look A T, Ashmun R A, Shapiro L H, et al. Human myeloid plasma membrane glycoprotein CD13(gp150)is identical to aminopeptidase N[J]. J Clin Invest, 1989,83():1299
[2]Gao J J, Xue X, Gao Z H, et al. LYP, a bestatin dimethylaminoethyl ester, inhibited Cancer angiogenesis both in vitro and in vivo[J]. Microvasc Res, 2011,82(2):122
[3]Bhagwat S V, Petrovic N, Okamoto Y, et al. The angiogenic regulator CD13/APN is a transcriptional target of Ras signaling pathways in endothelial morphogenesis[J]. Blood, 2003,101(5):1818
[4]Saiki I, Fujii H, Yoneda J, et al. Role of aminopeptidase N (CD13) in tumor-cell invasion and extracellular matrix degradation[J]. Int J Cancer, 1993,54(1):137
[5]Ranogajec I, Jaki?-Razumovi? J, Puzovi? V, et al. Prognostic value of matrix metalloproteinase-2 (MMP-2), matrix metalloproteinase-9 (MMP-9) and aminopeptidase N/CD13 in breast Cancer patients[J]. Med Oncol, 2012,29(2):561
[6]Ikeda N, Nakajima Y, Tokuhara T, et al. Clinical significance of aminopeptidase N/CD13 expression in human pancreatic carcinoma[J]. Clin Cancer Res, 2003,9(4):1503
[7]Tokuhara T, Hattori N, Ishida H, et al. Clinical significance of aminopeptidase N in non-small cell lung Cancer[J]. Clin Cancer Res, 2006,12(13):3971
[8]Inagaki Y, Tang W, Zhang L, et al. Novel aminopeptidase N (APN/CD13) inhibitor 24F can suppress invasion of hepatocellular carcinoma cells as well as angiogenesis[J]. Biosci Trends, 2010,4(2):56
[9]Dreischalück J, Schw?ppe C, Spieker T, et al. Vascular infarction by subcutaneous application of tissue factor targeted to tumor vessels with NGR-peptides: activity and toxicity profile[J]. Int J Oncol, 2010,37(6):1389
[10]Zhao B J, Ke X Y, Huang Y, et al. The antiangiogenic efficacy of NGR-modified PEG-DSPE micelles containing paclitaxel (NGR-M-PTX) for the treatment of glioma in rats[J]. J Drug Target, 2011,19(5):382
[11]Takara K, Hatakeyama H, Ohga N, et al. Design of a dual-ligand system using a specific ligand and cell penetrating peptide, resulting in a synergistic effect on selectivity and cellular uptake[J]. Int J Pharm, 2010,396(1/2):143
[12]Tsukamoto H, Shibata K, Kajiyama H, et al. Aminopeptidase N (APN)/CD13 inhibitor, Ubenimex, enhances radiation sensitivity in human cervical Cancer[J]. BMC Cancer, 2008,8:74
[13]Christ B, Stock P, Dollinger M M. CD13: waving the flag for a novel Cancer stem cell target[J]. Hepatology, 2011,53(4):1388
[14]Ichimura E, Yamada M, Nishikawa K, et al. Immunohistochemical expression of aminopeptidase N (CD13) in human lung squamous cell carcinomas, with special reference to Bestatin adjuvant therapy[J]. Pathol Int, 2006,56(6):296
[15] Bhagwat SV,?Lahdenranta J,?Giordano R ，et al. CD13/APN is activated by angiogenic signals and is essential for capillary tube formation[J]. Blood, 2001,97(3):652

相似文献/References:

[1]宋露露,宋文静.子宫内膜样癌及其前驱病变YAP1、PTEN和eIF4E的表达及意义[J].天津医科大学学报,2017,23(05):412.
　SONG Lu-lu,SONG Wen-jing.Expression and significance of YAP1, PTEN and eIF4E in endometrioid carcinoma and precursor lesions[J].Journal of Tianjin Medical University,2017,23(01):412.
[2]李辰运,孙 彤,卓 娜,等.胰腺导管腺癌中腺苷酸激酶4 的表达及临床意义[J].天津医科大学学报,2018,24(01):43.
　LI Chen-yun,SUN Tong,ZHUO Na,et al.Expression of AK4 in pancreatic ductal carcinoma and its clinical significance[J].Journal of Tianjin Medical University,2018,24(01):43.
[3]赵 朋,卢炳新,白铁男,等.MTA1和XIAP的表达与前列腺癌转移及预后的关系[J].天津医科大学学报,2019,25(03):260.
　ZHAO Peng,LU BING-Xin,BAI Tie-nan,et al.Expressions of MTA1 and XIAP protein in prostate carcinoma and its relationship with metastasis and prognosis[J].Journal of Tianjin Medical University,2019,25(01):260.
[4]胡 源,许戈良,荚卫东,等.C1QL1蛋白在原发性肝细胞癌中的表达及其临床意义[J].天津医科大学学报,2019,25(04):329.
　HU Yuan,XU Ge-liang,JIA Wei-dong,et al.Expressions of C1QL1 protein inprimaryhepatocellular carcinoma and its clinical significance[J].Journal of Tianjin Medical University,2019,25(01):329.
[5]曹文庆,宁殿宾,冯 丽,等.氨肽酶N在乳腺癌血管生成中的作用及其与VEGF的相关性[J].天津医科大学学报,2015,21(03):39.
　CAO Wen-qing,NING Dian-bin,FENG Li,et al.Functions of aminopeptidase N in breast cancer angiogenesis and its correlation with VEGF[J].Journal of Tianjin Medical University,2015,21(01):39.

备注/Memo

备注/Memo:
作者简介 曹文庆（1968-），男，主治医师，学士，研究方向：乳腺及甲状腺外科诊治及基础研究；通信作者：张静，E-mail： zhangjing166@126.com。
更新日期/Last Update: 2015-06-10